Home・Listă Acțiuni・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Închisă

SectorSănătate

575.5 -0.21

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

573.61

Maxim

577.21

Indicatori cheie
By Trading Economics
Venit	85M 1.7B
Vânzări	989M 12B
P/E Medie Sector	30.575 64.641
EPS	6.03
Randament dividend	0.15
Marjă de profit	14.516
Angajați	125,000
EBITDA	262M 2.6B

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+6.98% upside

Dividende
By Acuity
Randament dividend Medie Sector	0.15% 2.31%
Următoarele câștiguri	21 oct. 2026
Data viitoare de dividende	15 oct. 2026
Următoarea dată ex-dividende	15 sept. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	17B 213B
Deschiderea anterioară	575.71
Închiderea anterioară	575.5

Sentimentul știrilor

By Acuity

33%

67%

90 / 340 Clasament în Healthcare

Thermo Fisher Scientific Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 aug. 2026, 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

31 iul. 2026, 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30 iul. 2026, 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29 iul. 2026, 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28 iul. 2026, 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27 iul. 2026, 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24 iul. 2026, 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23 iul. 2026, 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22 iul. 2026, 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21 iul. 2026, 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20 iul. 2026, 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Comparație

Modificare preț

Thermo Fisher Scientific Inc Așteptări

Obiectiv de preț

By TipRanks

6.98% sus

Prognoză pe 12 luni

Medie 614.41 USD 6.98%

Maxim 690 USD

Minim 520 USD

În baza a 19 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruThermo Fisher Scientific Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

19 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 19 analiști care au acordat evaluări ale acțiunilor Thermo Fisher Scientific Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

90 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar